Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -45.96M
March 31, 2026 -40.23M
December 31, 2025 -36.12M
September 30, 2025 -26.44M
June 30, 2025 -34.21M
March 31, 2025 -27.63M
December 31, 2024 -26.73M
September 30, 2024 -30.15M
June 30, 2024 -18.57M
March 31, 2024 -21.32M
December 31, 2023 -23.96M
Date Value
September 30, 2023 -20.75M
June 30, 2023 -18.73M
March 31, 2023 -17.71M
December 31, 2022 -14.84M
September 30, 2022 -14.37M
June 30, 2022 -11.96M
March 31, 2022 -13.00M
December 31, 2021 -10.46M
September 30, 2021 -8.241M
June 30, 2021 0.6805M
March 31, 2021 6.537M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Merck & Co., Inc. 2.449B
EyePoint, Inc. -306.64M
Neumora Therapeutics, Inc. -212.74M
LENZ Therapeutics, Inc. -140.27M
ANI Pharmaceuticals, Inc. 99.95M